Loading
Total declarations
Company
▲ Purchases (8 ops.)
▼ Sales (1 ops.)
Latest filing published 17 Apr 2026 for Vivoryon Therapeutics N.V.. Read the official filing
Filing timeline
BuySaleM. Schaeffer
Insider track record
Disclosed buys
8
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
M. Schaeffer: trading record in brief
M. Schaeffer (board member) discloses dealings in Vivoryon Therapeutics N.V. to AFM. We count 9 filings; the first trade dates from 30 November 2020 and the latest from 17 April 2026.
The open-market side counts 8 purchases alongside 1 sale for €7,734. No amount is published for 8 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2026: 1 purchase and no sales on the market.
Most recently, on 17 April 2026, the filings show an open-market purchase in Vivoryon Therapeutics N.V. These figures are compiled from regulatory filings published by AFM. They describe what insiders did and are not a recommendation.
Companies and markets linked to M. Schaeffer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
150,000 shares0OptieAFM:192625
Canonical exit: 16 Jul 2026 (T+90)
75,000 shares0OptieAFM:171766
Canonical exit: 13 Jun 2025 (T+90)
120,000 shares0OptieAFM:159529
Canonical exit: 4 Sept 2024 (T+90)
-3,867 shares@ €2.00100.0% of flowGewoon aandeelAFM:155125
90,000 shares0OptieAFM:152998
Canonical exit: 9 Apr 2024 (T+90)
40,000 shares0OptieAFM:144118
Canonical exit: 9 Mar 2023 (T+90)
150,000 shares0OptieAFM:144117
Canonical exit: 24 Jul 2022 (T+90)
236,775 shares0OptieAFM:144116
Canonical exit: 4 Mar 2021 (T+90)
3,867 shares0Gewoon aandeelAFM:104867
Canonical exit: 28 Feb 2021 (T+90)
9 of 9 declarations
